Zobrazeno 1 - 10
of 75
pro vyhledávání: '"S R, Weiss"'
Autor:
S. R. Weiss, Andrew N. Freedman, L. B. Sansbury, J. L. Warren, C.-Y. Huang, Arnold L. Potosky, Alex Z. Fu, Huei-Ting Tsai, John L. Marshall
Publikováno v:
Annals of Oncology. 24:1574-1579
Cardiovascular risk attributable to bevacizumab (Avastin(®), BEV) for treatment of metastatic colorectal cancer (CRC) remains unclear. We conducted a population-based cohort study to assess the safety of BEV use among patients aged ≥ 65.We identif
Publikováno v:
Obstetrics & Gynecology. 94:330-336
Objective : To determine the effects of four doses of a 7-day transdermal 17β-estradiol (E2) delivery system, including 0.025 mg/day, on bone loss in postmenopausal women. Methods : This was a multicenter, double-masked, randomized, placebo-controll
Publikováno v:
Journal of neural transmission (Vienna, Austria : 1996). 112(11)
The time course and the relation to dose of locomotor activity and of the regional cerebral metabolic rates for glucose (rCMRglc) were measured in freely moving Sprague-Dawley rats after intracerebroventricular administration of ovine corticotropin r
Publikováno v:
Advances in experimental medicine and biology. 494
Publikováno v:
Advances in experimental medicine and biology. 494
Autor:
J C, Tsai, S R, Weiss
Publikováno v:
Advances in experimental medicine and biology. 494
Publikováno v:
Advances in experimental medicine and biology. 494
Autor:
P, Ravn, S R, Weiss, J A, Rodriguez-Portales, M R, McClung, R D, Wasnich, N L, Gilchrist, P, Sambrook, I, Fogelman, D, Krupa, A J, Yates, A, Daifotis, G E, Fuleihan
Publikováno v:
The Journal of clinical endocrinology and metabolism. 85(4)
We studied the effect on bone mass of alendronate treatment for 5 yr and its withdrawal. Four hundred and forty-seven postmenopausal women with normal bone mass entered a 3-yr randomized trial followed by a 2-yr open label extension. Three hundred an
Autor:
H G, Bone, S L, Greenspan, C, McKeever, N, Bell, M, Davidson, R W, Downs, R, Emkey, P J, Meunier, S S, Miller, A L, Mulloy, R R, Recker, S R, Weiss, N, Heyden, T, Musliner, S, Suryawanshi, A J, Yates, A, Lombardi
Publikováno v:
The Journal of clinical endocrinology and metabolism. 85(2)
The bisphosphonate alendronate and conjugated equine estrogens are both widely used for the treatment of postmenopausal osteoporosis. Acting by different mechanisms, these two agents decrease bone resorption and thereby increase or preserve bone mine
Publikováno v:
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996). 39(6)
To introduce the concept and design characteristics of pregnancy registries and to discuss opportunities for pharmacist involvement.Previous and ongoing pregnancy registry studies that assess the safety of pharmaceutical agents in pregnant women were